Details of the Drug

General Information of Drug (ID: DMK8EZD)

Drug Name

DeTIL-0255

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05107739) A Phase 1 Safety and Tolerability Study of DeTIL-0255 in Adults With Advanced Malignancies. U.S.National Institutes of Health.